000 01498 a2200421 4500
005 20250518060017.0
264 0 _c20200401
008 202004s 0 0 eng d
022 _a1873-3492
024 7 _a10.1016/j.cca.2019.08.034
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRael, Leonard T
245 0 0 _aThe presence of S-sulfonated transthyretin in commercial human serum albumin solutions: Potential contribution to neuropathy.
_h[electronic resource]
260 _bClinica chimica acta; international journal of clinical chemistry
_cDec 2019
300 _a70-74 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmyloid Neuropathies
_xmetabolism
650 0 4 _aChromatography, Liquid
650 0 4 _aCysteine
_xchemistry
650 0 4 _aHumans
650 0 4 _aMass Spectrometry
650 0 4 _aOxidation-Reduction
650 0 4 _aPrealbumin
_xanalysis
650 0 4 _aProteomics
650 0 4 _aSerum Albumin, Human
_xchemistry
650 0 4 _aSolutions
_xchemistry
700 1 _aBar-Or, Raphael
700 1 _aBanton, Kaysie L
700 1 _aMains, Charles W
700 1 _aMadayag, Robert M
700 1 _aMarshall, Gary T
700 1 _aAllen Tanner, I I
700 1 _aWaxman, Michael
700 1 _aAcuna, David L
700 1 _aBar-Or, David
773 0 _tClinica chimica acta; international journal of clinical chemistry
_gvol. 499
_gp. 70-74
856 4 0 _uhttps://doi.org/10.1016/j.cca.2019.08.034
_zAvailable from publisher's website
999 _c30071326
_d30071326